Interaction between ferric carboxymaltose and denosumab causing severe hypocalcaemia and hypophosphataemia in a patient without chronic kidney disease

被引：1

作者：

Muhandiramge, Jaidyn ^{[1
,2
]}

Lee, Vivian ^{[2
]}

Tran, Monica ^{[2
]}

Ho, Lannie ^{[2
]}

机构：

[1] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia

[2] Austin Hlth, Melbourne, Vic, Australia

来源：

INTERNAL MEDICINE JOURNAL | 2023年 / 53卷 / 07期

关键词：

ferric carboxymaltose; denosumab; hypocalcaemia; hypophosphataemia; osteoporosis; IRON;

D O I：

10.1111/imj.16156

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Coadministration of ferric carboxymaltose and denosumab may cause hypocalcaemia and hypophosphataemia; however, this interaction is not well-described in the literature and has typically been described in patients with chronic kidney disease (CKD). We present a case of this interaction in a patient without preexisting CKD. We suggest the use of alternative iron preparations and an interval of at least 4 weeks between administrations.

引用

页码：1273 / 1276

页数：4

共 15 条

[1] [Anonymous], MIMS ONLINE MONTHLY
[2] [Anonymous], 2020, AUSTR INJ DRUGS HDB
[3] [Anonymous], AUSTR MED HDB 2020
[4] Severe hypocalcaemia following denosumab and iron infusion
Cohen, Adrienne
Chacko, Bobby
[J]. NEPHROLOGY, 2022, 27 (09) : 781 - 782
[5] Hypocalcemia Post Denosumab in Patients with Chronic Kidney Disease Stage 4-5
Dave, Vatsa
Chiang, Cherie Y.
Booth, Jane
Mount, Peter F.
[J]. AMERICAN JOURNAL OF NEPHROLOGY, 2015, 41 (02) : 129 - 137
[6] Keith C., INTRAVENOUS IRON ADM
[7] Narayanan Prasad, 2013, South Asian J Cancer, V2, P272, DOI 10.4103/2278-330X.119895
[8] Incidence and risk of denosumab-related hypocalcemia in cancer patients: a systematic review and pooled analysis of randomized controlled studies
Qi, Wei-Xiang
Lin, Feng
He, Ai-Na
Tang, Li-Na
Shen, Zan
Yao, Yang
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (09) : 1067 - 1073
[9] Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis
Schaefer, Benedikt
Tobiasch, Moritz
Viveiros, Andre
Tilg, Herbert
Kennedy, Nicholas A.
Wolf, Myles
Zoller, Heinz
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (05) : 2256 - 2273
[10] Severe hypocalcaemia and hypophosphataemia following intravenous iron and denosumab: a novel drug interaction
Smyth, B.
Ong, S.
[J]. INTERNAL MEDICINE JOURNAL, 2016, 46 (03) : 360 - 363

← 1 2 →